triazolam has been researched along with Hip Fractures in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Hip Fractures: Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wysowski, DK | 1 |
| Baum, C | 1 |
| Ferguson, WJ | 1 |
| Lundin, F | 1 |
| Ng, MJ | 1 |
| Hammerstrom, T | 1 |
1 other study available for triazolam and Hip Fractures
| Article | Year |
|---|---|
Sedative-hypnotic drugs and the risk of hip fracture.
Topics: Accidental Falls; Aged; Aged, 80 and over; Anti-Anxiety Agents; Cohort Studies; Female; Florida; Hip | 1996 |